Health Tech
Redwood AI Signs LOI for AI-Enabled Pathogen Surveillance Initiative in East Africa
Redwood AI Corp. has signed a non-binding letter of intent to collaborate on a pathogen tracking and outbreak intelligence initiative in Central and East Africa, aiming to enhance early detection of infectious diseases using AI.
LataMed AI Evaluates Expansion into Fitness and Wellness Markets with AI Health Agent Deployment
LataMed AI Corp. is exploring opportunities to deploy its AI health platforms into fitness and wellness environments as part of its broader healthcare technology growth strategy, potentially expanding use cases for its digital health solutions.
HKTDC Brings 24 Hong Kong Startups to Paris VivaTech 2026 to Showcase Innovations and Attract Global Investment
The Hong Kong Trade Development Council will host a 'Hong Kong Tech Pavilion' at VivaTech 2026 in Paris, featuring 24 startups in AI, health tech, and sustainability to connect with global investors and foster international collaboration.
Qiari.ai Launches AI-Powered Frequency Wellness Platform for Personalized Remote Sessions
Qiari.ai introduces an AI-driven frequency wellness platform that delivers personalized remote sessions, marking a shift from static protocols to intelligent, adaptive digital health experiences.
HeartBeam Study Shows Portable ECG Device Can Help Identify Heart Attack Risk
A peer-reviewed study published in JACC: Advances demonstrates that HeartBeam's credit card-sized ECG device, combined with a risk prediction algorithm, can accurately identify heart attack risk in patients with chest pain, potentially enabling earlier detection and treatment.
HeartBeam's Portable ECG Device Shows Promise in Identifying Heart Attack Risk, Study Finds
A peer-reviewed study published in JACC: Advances demonstrates that HeartBeam's credit card-sized ECG device, combined with a risk prediction algorithm, can accurately identify heart attack risk in chest pain patients, with accuracy rising to 92.9% when a baseline ECG is available.
LataMed AI Corp. to Attend MEDICA 2026 in Germany as Part of Healthcare Technology Strategy
LataMed AI Corp. will attend MEDICA 2026 in Dusseldorf to evaluate technologies and build relationships for its digital healthcare platform in Latin America.
Visory Health Promotes Two Executives to C-Suite Amid Rapid Expansion
Visory Health announces promotions of Alexandra Robertson to Chief Growth Officer and Brittney Tierce to Chief Technology Officer, signaling the company's focus on scaling access to affordable prescription drugs.
HeartBeam Aims to Close Critical Gap in Early Cardiac Detection with Portable ECG System
HeartBeam is developing a cable-free, portable ECG system to address pre-hospital delays in cardiac care by enabling clinical-grade data collection outside clinical settings.
HeartBeam Aims to Close Critical Gap in Early Cardiac Detection with Portable ECG Platform
HeartBeam Inc. is developing a cable-free, high-fidelity ECG platform to address pre-hospital delays in cardiac care, with potential for future heart attack detection.
BioAdaptives Launches MyndSystem, a 24-Hour Cognitive Support Platform
BioAdaptives introduces MyndSystem, a dual-phase cognitive support platform combining daytime MyndMed and nighttime MyndRenew, originally developed for combat athletes.
Cardio Diagnostics Aims to Transform Heart Care with AI-Driven Personalized Medicine
Cardio Diagnostics Holdings is advancing a vision to shift cardiovascular care from reactive treatment to early prevention using AI, epigenetics, and genetic insights, aiming to reduce the global burden of heart disease.
Cardio Diagnostics Leverages AI and Epigenetics to Address Preventable Cardiovascular Disease
Cardio Diagnostics Holdings offers AI-powered solutions for cardiovascular disease prevention, targeting the 80% of cases considered preventable through earlier detection and personalized intervention.
LogicMark's Aster App Aims to Replace Informal Safety Habits with Structured Protection for Women
LogicMark's Aster app turns smartphones into personal safety devices, addressing the shortcomings of informal methods like texting friends or sharing location, and offering round-the-clock structured emergency support.
Wearable Wristband Shows Promise in Detecting Cardiac Arrest, Study Finds
New research published in Circulation: Arrhythmia and Electrophysiology demonstrates that a smart wristband using photoplethysmography can detect cardiac arrest with 92% accuracy in a clinical setting, potentially enabling faster emergency response and improved survival for out-of-hospital cardiac arrest.
Cardio Diagnostics Leverages AI to Address Preventable Cardiovascular Disease
Cardio Diagnostics Holdings Inc. offers AI-powered solutions for early detection and prevention of cardiovascular disease, addressing the urgent need for more effective risk identification tools.
Stonegate Initiates Coverage on StimCell Energetics, Highlighting eBalance Device Potential
Stonegate Capital Partners has initiated coverage on StimCell Energetics Inc., focusing on its single-product eBalance platform and the upcoming home-use redesign, with early data suggesting promise but requiring further validation.
Nutriband Subsidiary Active Intelligence to Showcase Wellness Products at ECRM Conference
Nutriband Inc. subsidiary Active Intelligence will present its expanding wellness product line, including AI Tape and new performance and sleep patches, at the June 2026 ECRM conference to secure retail partnerships.
LogicMark's AI-Driven Care Platform Shifts Focus from Reactive to Predictive Safety for Aging Population
LogicMark Inc. evolves personal emergency response systems with AI-powered predictive analytics and blockchain-secured data, addressing the growing demand for independent aging among older adults.
Lucent Psych Expands Telepsychiatry Services to Seattle and Texas, Improving Mental Health Access
Lucent Psych expands online psychiatry to Seattle, WA, and Round Rock, Cedar Park, and Cypress, TX, aiming to increase access for conditions like ADHD, anxiety, depression, and PTSD.
HeartBeam Advances Commercial Launch, Reports Improved Q1 2026 Results
HeartBeam reported first-quarter 2026 results highlighting initial commercial partnerships in key U.S. markets and an $11.5 million public offering, as it advances its FDA-cleared 3D ECG platform for heart attack detection and ambulatory monitoring.
AI and Multi-Omics Converge: Cardio Diagnostics Targets Earlier, More Precise Cardiac Insights
Cardio Diagnostics Holdings is leveraging artificial intelligence and multi-omic biomarkers to improve early detection and personalized treatment of cardiovascular disease, addressing a critical gap in traditional risk assessment.
Aclarion Expands Commercial Team Amid Triple-Digit Growth in Nociscan Utilization
Aclarion granted inducement stock options to its new Western U.S. Commercial Director as demand for its Nociscan platform surges, reflecting strong adoption of its AI-driven chronic low back pain diagnostic tool.
HeartBeam Targets Heart Disease with Advanced ECG Technology as Cardiovascular Deaths Surge
HeartBeam Inc. is developing next-generation ECG solutions to address the gap in early cardiac detection, as cardiovascular disease remains the leading cause of death in the U.S. with over 919,000 deaths in 2023.
Cardio Diagnostics Harnesses AI and Biomarkers to Combat Heart Disease Burden
Cardio Diagnostics Holdings is advancing early detection of cardiovascular disease using an AI-powered platform that analyzes epigenetic and genetic biomarkers from a simple blood sample, addressing the leading cause of death in the U.S.
Cardio Diagnostics Leverages AI and Biomarkers to Combat Cardiovascular Disease
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) is advancing early detection of heart disease using a platform that combines artificial intelligence with multi-omic biomarker analysis, addressing the urgent need for innovation in cardiovascular care.
ResQ Launches Fall Detection Series and Mahi Collection, Blending Safety with Style
ResQ introduces automatic fall detection and a new jewelry-inspired line, enhancing personal safety wearables with design and technology.
Cardio Diagnostics Targets Precision Cardiology with Multi-Omic AI Platform
Cardio Diagnostics Holdings (NASDAQ: CDIO) leverages AI to integrate epigenetic and genetic biomarkers for personalized cardiovascular risk assessments, potentially transforming disease prevention and treatment.
HeartBeam to Report Q1 Earnings, Update on Commercial Launch and AI Initiatives
HeartBeam Inc. will host a Q1 2026 earnings call to discuss financial results and provide updates on its limited commercial launch for arrhythmia assessment, extended-wear patch development, and AI programs, marking a pivotal moment for the company's cardiac care innovations.
Ventripoint's AI-Powered Cardiac Imaging System Submitted for Expedited Approval in China
Ventripoint Diagnostics announced that its VMS+ 4.0 system has been submitted for regulatory approval in China via an expedited 'green channel' pathway, potentially accelerating access to AI-driven cardiac diagnostics in a market with 330 million cardiovascular patients.